BusinessNovel treatment of hemophilia: OMRF enters license agreement with Shanghai RAAS Blood ProductsBy Nasdaq OMXFeb 13, 2018, 8:02 PM UTC
BusinessGlobal Hemophilia Market (TYPE: Hemophilia A, Hemophilia B, Hemophilia C) With increasing sophistication and modernization of technology, demand for advanced treatment leading the market to grow - 2016 Edition: ResearchMozBy Nasdaq OMXApr 13, 2016, 12:30 PM UTC
